Drugs / P7435
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01910571 | Aug 2013 → Nov 2014 | — | Piramal Enterprises Limited | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01764425 Comparator | May → Sep 2012 | — | Piramal Enterprises Limited | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P7435 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01910571 ↗ |
| Action | Inhibit | “It is oral DGATI inhibitor with potential in dyslipidemia and T2DM” NCT01764425 ↗ |
| Route | Oral | “Tablets for once daily oral administration” NCT01764425 ↗ |